ClassID:

108937

C12N9/22 - page 7 - CPC Classification

Classification description:

Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on ester bonds (3.1) Ribonucleases RNAses, DNAses

Recent Application in this class:
#1801
20240110203
2024-04-04

DNA NUCLEASE GUIDED TRANSPOSASE COMPOSITIONS AND METHODS OF USE THEREOF

#1802
20240110198
2024-04-04

METHOD OF PROVIDING BROAD-SPECTRUM RESISTANCE TO PLANTS, AND PLANTS THUS OBTAINED

#1803
20240110194
2024-04-04

COMPOSITIONS AND METHODS FOR TRANSFORMATION OF EMBRYO EXPLANT POPULATIONS

#1804
20240110189
2024-04-04

COMPOSITIONS AND METHODS FOR CLL1 MODIFICATION

#1805
20240110183
2024-04-04

ANTIFIBROTIC AND ANTITUMOR ACTIVITY OF CD63 BLOCKADE

#1806
20240110182
2024-04-04

GENOMIC EDITING OF COMPLEMENT

#1807
20240110179
2024-04-04

SYSTEMS AND METHODS FOR TREATING ALPHA 1-ANTITRYPSIN (A1AT) DEFICIENCY

#1808
20240110178
2024-04-04

Application of prokaryotic Argonaute protein with only RNA target cleavage activity in RNA editing

#1809
20240110176
2024-04-04

PHOSPHOROTHIOATE NUCLEIC ACID CONJUGATES INCLUDING DNA EDITING ENZYMES

#1810
20240110175
2024-04-04

COMPOSITION AND METHOD FOR HIGH-MULTIPLEXED GENOME ENGINEERING USING SYNTHETIC CRISPR ARRAYS

#1811
20240110167
2024-04-04

ENZYMES WITH RUVC DOMAINS

#1812
20240110166
2024-04-04

EDITING OF CCR5 RECEPTOR GENE TO PROTECT AGAINST HIV INFECTION

#1813
20240110165
2024-04-04

NOVEL TYPE VI CRISPR ORTHOLOGS AND SYSTEMS

#1814
20240110164
2024-04-04

Delivery of therapeutics in vivo via a CRISPR-based cascade system

#1815
20240110163
2024-04-04

CRISPR-ASSOCIATED BASED-EDITING OF THE COMPLEMENTARY STRAND

#1816
20240109940
2024-04-04

Methods and products for genetic engineering

#1817
20240108757
2024-04-04

ENGINEERED EXTRACELLULAR VESICLES AND THEIR USES

#1818
20240108751
2024-04-04

RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING MYOTONIC DYSTROPHY TYPE 1

#1819
20240108689
2024-04-04

MODULATION OF A PATHOGENIC PHENOTYPE IN TH1 CELLS

#1820
20240107988
2024-04-04

DOWN-REGULATION OF ENDOGENOUS GENES

#1821
20240102115
2024-03-28

CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS FOR VIRUS DETECTION

#1822
20240102113
2024-03-28

SILICA-BASED CHROMATOGRAPHIC PROCESSES FOR ISOLATING NUCLEIC ACID-PROTEIN COMPLEXES AND DETECTING TARGET NUCLEIC ACIDS

#1823
20240102084
2024-03-28

COMPOSITIONS AND METHODS FOR DETECTION OF A NUCLEIC ACID

#1824
20240102070
2024-03-28

FUNGAL STRAINS COMPRISING ENHANCED PROTEIN PRODUCTIVITY PHENOTYPES AND METHODS THEREOF

#1825
20240102053
2024-03-28

Method for Producing Genetically Engineered Cells

#1826
20240102052
2024-03-28

PNMA2-BASED CAPSIDS AND USES THEREOF

#1827
20240102035
2024-03-28

OLEIC ACID -ENRICHED PLANT BODY HAVING GENETICALLY MODIFIED FAD2 AND PRODUCTION METHOD THEREOF

#1828
20240102034
2024-03-28

CANNABIS PLANT WITH INCREASED CANNABIGEROLIC ACID

#1829
20240102032
2024-03-28

CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF

#1830
20240102029
2024-03-28

TWO-PLASMID SYSTEM FOR PRIME EDITING IN YEAST, USE THEREOF, AND METHOD FOR PRIME EDITING IN YEAST

#1831
20240102007
2024-03-28

GENE EDITING SYSTEMS COMPRISING A CRISPR NUCLEASE AND USES THEREOF

#1832
20240102001
2024-03-28

COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFICIENCY GENE DISRUPTION

#1833
20240101993
2024-03-28

ENHANCING EFFICIENCY OF TARGETED GENE KNOCKIN BY BASE EDITORS

#1834
20240101990
2024-03-28

CRISPR DNA TARGETING ENZYMES AND SYSTEMS

#1835
20240101989
2024-03-28

NUCLEASE-MEDIATED GENOME EDITING

#1836
20240101988
2024-03-28

TEMPERATURE-SENSITIVE CAS9 PROTEIN

#1837
20240101987
2024-03-28

POLYPEPTIDE FUSIONS OR CONJUGATES FOR GENE EDITING

#1838
20240101986
2024-03-28

ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE PCSK9 GENE

#1839
20240101985
2024-03-28

ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE PCSK9 GENE

#1840
20240101984
2024-03-28

COMPOSITIONS AND METHODS FOR THE TARGETING OF SOD1

#1841
20240101983
2024-03-28

PROGRAMMABLE RNA EDITING PLATFORM

#1842
20240101982
2024-03-28

Paraoxonase fusion polypeptides and related compositions and methods

#1843
20240101976
2024-03-28

Genetically modified organisms for producing psychotropic alkaloids

#1844
20240101967
2024-03-28

COMPOSITIONS AND METHODS FOR GENE EDITING WITH WOOLLY MAMMOTH ALLELES

#1845
20240101606
2024-03-28

Synthetic system for tunable thresholding of protein signals

#1846
20240101590
2024-03-28

Method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides

#1847
20240100192
2024-03-28

PROGRAMMABLE RNA WRITING USING CRISPR EFFECTORS AND TRANS-SPLICING TEMPLATES

#1848
20240100188
2024-03-28

REGULATORY SYSTEM FOR EXPRESSION OF A GENE OF INTEREST IN A TARGET CELL AND METHOD OF USE THEREOF

#1849
20240100185
2024-03-28

COMPOSITIONS AND METHODS FOR THE TARGETING OF PTBP1

#1850
20240100184
2024-03-28

METHODS OF PRECISE GENOME EDITING BY IN SITU CUT AND PASTE (ICAP)

#1851
20240099210
2024-03-28

METHOD FOR PRODUCING TEMPERATURE-SENSITIVE MALE STERILE PLANT

#1852
20240093316
2024-03-21

CAS-READY MOUSE EMBRYONIC STEM CELLS AND MICE AND USES THEREOF

#1853
20240093247
2024-03-21

GENETICALLY ENGINEERED STRAIN OF ZYMOMONAS MOBILIS AND USES THEREOF

#1854
20240093243
2024-03-21

METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELL BY USING CRISPR/CAS SYSTEM

#1855
20240093242
2024-03-21

GENE CORRECTION FOR SCID-X1 IN LONG-TERM HEMATOPOIETIC STEM CELLS

#1856
20240093241
2024-03-21

CRISPR ENABLED MULTIPLEXED GENOME ENGINEERING

#1857
20240093240
2024-03-21

GENE FUNCTION CONTROL BY NOVEL GUIDE NUCLEIC ACID MECHANISM

#1858
20240093239
2024-03-21

Class II, type V CRISPR systems

#1859
20240093228
2024-03-21

COMPOSITIONS COMPRISING A NUCLEASE AND USES THEREOF

#1860
20240093215
2024-03-21

BIOCONTAINMENT/BIOCONTROL SYSTEM AND METHODS

#1861
20240093214
2024-03-21

Methods and compositions for generating complex trait loci

#1862
20240093208
2024-03-21

DE NOVO ENGINEERING OF A BACTERIAL LIFESTYLE PROGRAM

#1863
20240093207
2024-03-21

NON-TOXIC CAS9 ENZYME AND APPLICATION THEREOF

#1864
20240093193
2024-03-21

DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS

#1865
20240093190
2024-03-21

ENGINEERED NUCLEIC ACIDS TARGETING LONG NONCODING RNA INVOLVED IN PATHOGENIC INFECTION

#1866
20240093186
2024-03-21

CFTR-modulating compositions and methods

#1867
20240093185
2024-03-21

Circular RNAS and preparation methods thereof

#1868
20240093169
2024-03-21

SYNTHETIC TRANSCRIPTION FACTORS

#1869
20240093168
2024-03-21

TRANSCRIPTIONAL PRODUCT IN CELLS OF ORGANISM INCLUDING HUMAN, TRANSFECTED RNA, AND TOOL FOR PURIFYING COMPLEX THEREOF

#1870
20240093152
2024-03-21

ECTOPIC CELLULAR GROWTH FACTOR EXPRESSION FOR LOW-COST PRODUCTION OF CELL-CULTURED FOODS

#1871
20240093126
2024-03-21

Polypeptide variants

#1872
20240091381
2024-03-21

ABCA4 TRANS-SPLICING MOLECULES

#1873
20240091379
2024-03-21

COMPOSITIONS AND METHODS FOR UPREGULATING ISOFORMS OF DYSTROPHIN AS THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY (DMD)

#1874
20240091378
2024-03-21

Compositions and methods of treating ocular diseases

#1875
20240091332
2024-03-21

COMPOUNDS AND METHODS FOR BIOFILM DISRUPTION AND PREVENTION

#1876
20240091261
2024-03-21

IMMUNE CELL FUNCTION

#1877
20240091256
2024-03-21

GENETIC ENGINEERING OF MACROPHAGES FOR IMMUNOTHERAPY

#1878
20240090479
2024-03-21

HYPERPROLACTINEMIA OR LACTATION WITHOUT PREGNANCY

#1879
20240090466
2024-03-21

METHODS AND COMPOSITIONS FOR IMPROVING YIELD CHARACTERISTICS IN PLANTS

#1880
20240085406
2024-03-14

MULTI-CHAMBER DEVICE FOR DETECTING PATHOGENS/MOLECULES AND METHODS OF USING SAME

#1881
20240084401
2024-03-14

HIGH-PLEX GUIDE POOLING FOR NUCLEIC ACID DETECTION

#1882
20240084364
2024-03-14

Crispr enzymes and systems

#1883
20240084335
2024-03-14

CHIMERIC PROTEINS AND METHODS OF REGULATING GENE EXPRESSION

#1884
20240084334
2024-03-14

SERPINA-MODULATING COMPOSITIONS AND METHODS

#1885
20240084333
2024-03-14

Methods and compositions for modulating a genome

#1886
20240084332
2024-03-14

REPROGRAMMABLE TNPB POLYPEPTIDES AND USE THEREOF

#1887
20240084331
2024-03-14

Methods and Systems for Guide RNA Design and Use

#1888
20240084330
2024-03-14

COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL

#1889
20240084320
2024-03-14

COMPOSITIONS AND METHODS FOR ALTERING STEM LENGTH IN SOLANACEAE

#1890
20240084316
2024-03-14

METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR

#1891
20240084313
2024-03-14

HIV Pseudovirus Particles and Method for Preparing the Same

#1892
20240084294
2024-03-14

METHODS AND COMPOSITIONS FOR INDUCING TUMOR CELL DEATH

#1893
20240084293
2024-03-14

CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation

#1894
20240084285
2024-03-14

METHOD FOR PRODUCING TARGET DNA SEQUENCE AND CLONING VECTOR

#1895
20240084276
2024-03-14

ENGINEERED MEGANUCLEASES THAT TARGET HUMAN MITOCHONDRIAL GENOMES

#1896
20240084275
2024-03-14

COMPOSITIONS AND METHODS OF USING PROGRAMMABLE NUCLEASES FOR INDUCING CELL DEATH

#1897
20240084274
2024-03-14

GENE EDITING COMPONENTS, SYSTEMS, AND METHODS OF USE

#1898
20240082430
2024-03-14

GENE THERAPY FOR TREATMENT OF INFERTILITY

#1899
20240082429
2024-03-14

PAH-MODULATING COMPOSITIONS AND METHODS

#1900
20240082327
2024-03-14

RETROVIRAL VECTORS

#1901
20240081302
2024-03-14

METHOD OF PREPARING ANTIBODY CARRYING A UNIVERSAL SITE-DIRECTED COUPLING INTERFACE BASED ON GENETICALLY MODIFIED VERTEBRATE

#1902
20240077516
2024-03-07

SYSTEM, METHOD, COMPUTER-ACCESSIBLE MEDIUM AND APPARATUS FOR DNA MAPPING

#1903
20240076718
2024-03-07

CRISPNA FOR GENOME EDITING

#1904
20240076712
2024-03-07

COMPOSITIONS AND METHODS FOR INSTANT NUCLEIC ACID DETECTION

#1905
20240076698
2024-03-07

Methods and compositions for modulating a genome

#1906
20240076697
2024-03-07

METHODS FOR INCREASED NUCLEIC ACID-GUIDED CELL EDITING

#1907
20240076684
2024-03-07

INIR19 TRANSGENIC SOYBEAN WITH JUNCTION POLYNUCLEOTIDE DELETIONS

#1908
20240076683
2024-03-07

INHT20 TRANSGENIC SOYBEAN WITH JUNCTION POLYNUCLEOTIDE DELETIONS

#1909
20240076678
2024-03-07

COMPOSITIONS AND METHODS FOR EPIGENETIC EDITING

#1910
20240076662
2024-03-07

Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)

#1911
20240076660
2024-03-07

GENE CORRECTION OF POMPE DISEASE AND OTHER AUTOSOMAL RECESSIVE DISORDERS VIA RNA-GUIDED NUCLEASES

#1912
20240076656
2024-03-07

HIGH DEFINITION MOLECULAR ARRAY FEATURE GENERATION USING PHOTORESIST

#1913
20240076652
2024-03-07

Adenosine nucleobase editors and uses thereof

#1914
20240076651
2024-03-07

SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING

#1915
20240076640
2024-03-07

VARIANTS OF CAS12A NUCLEASES AND METHODS OF MAKING AND USE THEREOF

#1916
20240076639
2024-03-07

VARIANTS OF CAS12A NUCLEASES AND METHODS OF MAKING AND USE THEREOF

#1917
20240076638
2024-03-07

Methods and compositions for modulating a genome

#1918
20240076637
2024-03-07

TRANSPOSASE-MEDIATED IMAGING OF THE ACCESSIBLE GENOME

#1919
20240076636
2024-03-07

Polynucleotides, Compositions, and Methods for Genome Editing

#1920
20240075167
2024-03-07

METHOD OF GENE DELIVERY TO RETINAL ASTROCYTES

#1921
20240075166
2024-03-07

METHODS AND COMPOSITIONS FOR TREATING TUMOR CELLS

#1922
20240075164
2024-03-07

IN UTERO CRISPR-MEDIATED THERAPEUTIC EDITING OF GENES

#1923
20240068048
2024-02-29

METHOD OF MODIFYING GENOMIC DNA AND METHOD OF DETECTING MODIFICATION

#1924
20240067992
2024-02-29

HUMAN HEMATOPOIETIC STEM CELL HAVING A MODIFIED BCL11A GENE AND METHODS OF MAKING THE CELL

#1925
20240067991
2024-02-29

SYSTEMS AND METHODS FOR REGULATING GENE EXPRESSION OR ACTIVITY

#1926
20240067983
2024-02-29

Guide RNA Designs and Complexes for Tracr-less Type V Cas Systems

#1927
20240067982
2024-02-29

RNA-DIRECTED DNA CLEAVAGE AND GENE EDITING BY CAS9 ENZYME FROM NEISSERIA MENINGITIDIS

#1928
20240067969
2024-02-29

Compositions, systems, and methods for regulation of hepatitis B virus through targeted gene repression

#1929
20240067968
2024-02-29

Compositions, systems, and methods for regulation of hepatitis b virus through targeted gene repression

#1930
20240067961
2024-02-29

Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)

#1931
20240067958
2024-02-29

ENGINEERED ENVELOPED VECTORS AND METHODS OF USE THEREOF

#1932
20240067954
2024-02-29

METHOD FOR PRODUCING GENETICALLY MODIFIED CELLS

#1933
20240067943
2024-02-29

Polypeptides

#1934
20240067940
2024-02-29

METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES

#1935
20240067935
2024-02-29

ALTERING THE NORMAL BALANCE OF MICROBIAL POPULATIONS

#1936
20240066150
2024-02-29

MATERIALS AND METHODS FOR TREATMENT OF PAIN RELATED DISORDERS

#1937
20240066148
2024-02-29

GLOBIN GENE THERAPY FOR TREATING HEMOGLOBINOPATHIES

#1938
20240066080
2024-02-29

PROTOPARVOVIRUS AND TETRAPARVOVIRUS COMPOSITIONS AND METHODS FOR GENE THERAPY

#1939
20240066063
2024-02-29

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A TGFßRII ENGINEERED T CELL THERAPY

#1940
20240060091
2024-02-22

METHOD FOR PROGRAMMABLE CONTROL OF RNA TRANSCRIPT LEVELS WITH AUTOREGULATED CRISPR-CAS13D

#1941
20240060090
2024-02-22

GENETICALLY MODIFIED INDUCED PLURIPOTENT STEM CELLS AND METHODS OF USE THEREOF

#1942
20240060089
2024-02-22

VECTOR-FREE PROCESS FOR MANUFACTURE OF ENGINEERED IMMUNE CELLS

#1943
20240060088
2024-02-22

Guide RNA Designs and Complexes for Type V Cas Systems

#1944
20240060077
2024-02-22

INIR11 TRANSGENIC MAIZE WITH JUNCTION SEQUENCE DELETIONS

#1945
20240060061
2024-02-22

DNASE VARIANTS

#1946
20240059742
2024-02-22

Antibody-evading virus vectors

#1947
20240058425
2024-02-22

SYSTEMS AND METHODS FOR GENOME-WIDE ANNOTATION OF GENE REGULATORY ELEMENTS LINKED TO CELL FITNESS

#1948
20240052396
2024-02-15

SELECTIVE PROTECTION OF NUCLEIC ACIDS

#1949
20240052373
2024-02-15

ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE

#1950
20240052372
2024-02-15

ALLELE-SPECIFIC GENOME EDITING OF THE NR2E3 MUTATION G56R

#1951
20240052371
2024-02-15

PROGRAMMABLE TRANSPOSASES AND USES THEREOF

#1952
20240052370
2024-02-15

MODULATING CELLULAR REPAIR MECHANISMS FOR GENOMIC EDITING

#1953
20240052365
2024-02-15

METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME

#1954
20240052361
2024-02-15

COMPOSITIONS AND METHODS TO INCREASE RESISTANCE TO PHYTOPHTHORA SOJAE IN SOYBEAN

#1955
20240052360
2024-02-15

TRANSGENIC PLANT WITH REDUCED HEAVY METALS AND METHODS FOR PREPARATION THEREOF

#1956
20240052359
2024-02-15

MULTIPLEX TARGETED RECOMBINATIONS FOR TRAIT INTROGRESSION APPLICATIONS

#1957
20240052356
2024-02-15

Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells

#1958
20240052354
2024-02-15

COMPOSITIONS AND METHODS TO TREAT CANCER

#1959
20240052329
2024-02-15

Polypeptides

#1960
20240052328
2024-02-15

Compositions, systems, and methods for epigenetic regulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) gene expression

#1961
20240052309
2024-02-15

METHOD FOR PRODUCING REGENERATED T CELL VIA IPS CELL

#1962
20240052004
2024-02-15

TARGETING CAP-DEPENDENT TRANSLATION TO REDUCE SEIZURES IN MTOR DISORDERS

#1963
20240051999
2024-02-15

METHODS FOR TARGETED PROTEIN DEGRADATION

#1964
20240050660
2024-02-15

Method Of Using A Plungerless Aspiration And/Or Injection Device

#1965
20240050589
2024-02-15

TREATMENT OF NEUROLOGICAL DISEASES

#1966
20240050476
2024-02-15

COMBINATION OF DEOXYRIBONUCLEASE ENZYME AND CELL THERAPIES FOR TREATMENT OF CANCER

#1967
20240043877
2024-02-08

COMPOSITIONS AND METHODS FOR GENETIC MANIPULATION OF METHANOTROPHS

#1968
20240043875
2024-02-08

A PLASMID FOR TRANSFORMATION, A METHOD FOR PRODUCING A TRANSFORMANT USING THE SAME AND A METHOD OF TRANSFORMATION

#1969
20240043857
2024-02-08

METHODS AND COMPOSITIONS FOR IMPROVING YIELD TRAITS

#1970
20240043854
2024-02-08

Phage-derived particles for in situ delivery of DNA payload into population

#1971
20240043852
2024-02-08

DUAL STRAND NUCLEIC ACID-GUIDED NICKASE EDITING

#1972
20240043851
2024-02-08

NON-TOXIC CAS9 ENZYME AND APPLICATION THEREOF

#1973
20240043848
2024-02-08

RESCUE STRATEGIES FOR BEST1 LOSS- AND GAIN-OF-FUNCTION MUTATIONS

#1974
20240043830
2024-02-08

MULTIPLEX EPIGENOME EDITING

#1975
20240043828
2024-02-08

T-DNA MEDIATED GENETIC MODIFICATION

#1976
20240043820
2024-02-08

ENZYME VARIANTS

#1977
20240043819
2024-02-08

MODIFIED CAS9 SYSTEM HAVING A DOMINANT NEGATIVE EFFECTOR ON NON-HOMOLOGOUS END-JOINING FUSED THERETO AND ITS USE FOR IMPROVED GENE EDITING

#1978
20240043818
2024-02-08

Engineered Cells for Increased Collagen Production

#1979
20240042057
2024-02-08

ABCA4 TRANS-SPLICING MOLECULES

#1980
20240042029
2024-02-08

DELIVERY OF MOLECULES TO CELLS USING TROGOCYTOSIS AND ENGINEERED CELLS

#1981
20240042025
2024-02-08

BIALLELIC KNOCKOUT OF B2M

#1982
20240041990
2024-02-08

APPLICATION OF CRISPR/CAS13 FOR THERAPY OF RNA VIRUS AND/OR BACTERIUM INDUCED DISEASES

#1983
20240041932
2024-02-08

COMPOSITIONS AND METHODS FOR CD5 MODIFICATION

#1984
20240041923
2024-02-08

COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS USING CRISPR-BASED BASE EDITOR SYSTEMS

#1985
20240041757
2024-02-08

LIPID NANOPARTICLES (LNPs)-BASED OCULAR DELIVERY

#1986
20240041010
2024-02-08

GENERATION OF SURROGATE SIRES AND DAMS BY ABLATION OF ENDOGENOUS GERMLINE

#1987
20240035049
2024-02-01

Methods and compositions for modulating a genome

#1988
20240035048
2024-02-01

DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS

#1989
20240035039
2024-02-01

PLANT REGULATORY ELEMENTS AND USES THEREOF FOR AUTOEXCISION

#1990
20240035038
2024-02-01

CUTIBACTERIUM ACNES RECOMBINANT PHAGES, METHOD OF PRODUCTION AND USES THEREOF

#1991
20240035031
2024-02-01

Targeted trans-splicing using CRISPR/Cas13

#1992
20240035028
2024-02-01

SIGNAL BOOST CASCADE ASSAY

#1993
20240035025
2024-02-01

CIRCULAR RNA

#1994
20240035017
2024-02-01

CYTOSINE TO GUANINE BASE EDITOR

#1995
20240035011
2024-02-01

OPTIMIZED ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HEPATITIS B VIRUS GENOME

#1996
20240035010
2024-02-01

COMPOSITIONS COMPRISING A VARIANT POLYPEPTIDE AND USES THEREOF

#1997
20240035009
2024-02-01

Engineered nucleases, compositions, and methods of use thereof

#1998
20240035008
2024-02-01

GENOMIC EDITING WITH SITE-SPECIFIC RETROTRANSPOSONS

#1999
20240035007
2024-02-01

Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems

#2000
20240035006
2024-02-01

CRYSTAL STRUCTURE OF CRISPR CPF1

#2001
20240034961
2024-02-01

ENZYMES AND ENZYME COMPOSITIONS FOR CLEANING

#2002
20240034756
2024-02-01

Brassica plants with increased locules

#2003
20240033377
2024-02-01

AAV VECTORS FOR GENE EDITING

#2004
20240033362
2024-02-01

LIPID COMPOSITION FOR THE DELIVERY OF THERAPEUTIC CARGOS

#2005
20240033290
2024-02-01

COMPOSITIONS AND METHODS FOR CD7 MODIFICATION

#2006
20240033227
2024-02-01

COMPOSITIONS FOR FACILITATING MEMBRANE FUSION AND USES THEREOF

#2007
20240032515
2024-02-01

METHOD FOR PRODUCING BIRD PRODUCING HUMAN IMMUNOGLOBULIN FC AND TARGET PROTEIN

#2008
20240026425
2024-01-25

Compositions of matter for detection assays

#2009
20240026424
2024-01-25

REAGENT AND METHOD FOR DETECTING TARGET NUCLEIC ACID USING SAME

#2010
20240026386
2024-01-25

COMPOSITIONS AND METHODS FOR THE TARGETING OF BCL11A

#2011
20240026385
2024-01-25

ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS

#2012
20240026384
2024-01-25

RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE

#2013
20240026383
2024-01-25

UNIVERSAL RIBOSWITCH FOR INDUCIBLE GENE EXPRESSION

#2014
20240026382
2024-01-25

Small type II-D Cas proteins and methods of use thereof

#2015
20240026381
2024-01-25

SPLIT PRIME EDITING PLATFORMS

#2016
20240026375
2024-01-25

METHODS AND COMPOSITIONS FOR NUCLEIC ACID AND PROTEIN PAYLOAD DELIVERY

#2017
20240026369
2024-01-25

USE OF ENHANCED POL THETA ACTIVITY FOR EUKARYOTIC GENOME ENGINEERING

#2018
20240026367
2024-01-25

Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells

#2019
20240026352
2024-01-25

TARGETED GENE REGULATION OF HUMAN IMMUNE CELLS WITH CRISPR-CAS SYSTEMS

#2020
20240026351
2024-01-25

COMPOSITIONS COMPRISING AN RNA GUIDE TARGETING TRAC AND USES THEREOF

#2021
20240026350
2024-01-25

NUCLEIC ACID CONSTRUCTS COMPRISING GENE EDITING MULTI-SITES

#2022
20240026342
2024-01-25

INHIBITION OF UNINTENDED MUTATIONS IN GENE EDITING

#2023
20240026324
2024-01-25

Methods and compositions for modulating a genome

#2024
20240026323
2024-01-25

COMPOSITIONS AND METHODS FOR MODIFYING RNA

#2025
20240026322
2024-01-25

NOVEL NUCLEIC ACID-GUIDED NUCLEASES

#2026
20240026321
2024-01-25

CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF

#2027
20240026320
2024-01-25

MATERIALS AND METHODS FOR MODIFYING EXPRESSION OF MYOSIN HEAVY CHAIN GENES

#2028
20240026319
2024-01-25

Angiogenin expression in plants

#2029
20240026292
2024-01-25

ENGINEERED IMMUNE CELLS FOR REAGENT DELIVERY

#2030
20240025939
2024-01-25

HIGH SEQUENCE FIDELITY NUCLEIC ACID SYNTHESIS AND ASSEMBLY

#2031
20240024478
2024-01-25

Compositions and Methods for Reducing HLA-A in a Cell

#2032
20240024382
2024-01-25

Method and system to modify an individual's gut-brain axis to provide neurocognitive protection

#2033
20240024368
2024-01-25

COMPOSITIONS AND METHODS FOR NEUROPROTECTION AND/OR NEUROREGENERATION

#2034
20240023528
2024-01-25

ONE-LOCUS INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE OR TEMPERATURE-INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE

#2035
20240018570
2024-01-18

DETERMINATION OF BASE MODIFICATIONS OF NUCLEIC ACIDS

#2036
20240018551
2024-01-18

METHODS AND COMPOSITIONS FOR MODULATING A GENOME

#2037
20240018550
2024-01-18

ADENINE BASE EDITOR HAVING INCREASED THYMINE-CYTOSINE SEQUENCE-SPECIFIC CYTOSINE EDITING ACTIVITY, AND USE THEREOF

#2038
20240018542
2024-01-18

CO-PACKAGING TO MITIGATE INTERMOLECULAR RECOMBINATION

#2039
20240018533
2024-01-18

TARGETING MICRORNA TO REGULATE NATIVE GENE FUNCTION BY GENOME EDITING

#2040
20240018531
2024-01-18

INIR4 TRANSGENIC MAIZE

#2041
20240018530
2024-01-18

INIR17 TRANSGENIC MAIZE

#2042
20240018497
2024-01-18

CAS9 VARIANTS AND METHODS OF USE

#2043
20240018496
2024-01-18

Compositions and Methods for Kallikrein (KLKB1) Gene Editing

#2044
20240018495
2024-01-18

Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

#2045
20240018494
2024-01-18

NOVEL CAS13B ORTHOLOGUES CRISPR ENZYMES AND SYSTEMS

#2046
20240018493
2024-01-18

KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION

#2047
20240018492
2024-01-18

PRIME EDITING USING HIV REVERSE TRANSCRIPTASE AND CAS9 OR VARIANT THEREOF

#2048
20240018471
2024-01-18

Engineered red blood cells having rare antigen phenotypes

#2049
20240016855
2024-01-18

TARGETED-ANTIBACTERIAL-PLASMIDS COMBINING CONJUGATION AND CRISPR/CAS SYSTEMS AND USES THEREOF

#2050
20240016838
2024-01-18

ENGINEERED NK CELLS

#2051
20240016129
2024-01-18

Non-human animals comprising a humanized coagulation factor 12 locus

#2052
20240013063
2024-01-11

Systems for nucleic acid-based data storage

#2053
20240011073
2024-01-11

METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS

#2054
20240011066
2024-01-11

PRODUCTION CELLS

#2055
20240011055
2024-01-11

PRECISE GENOME DELETION AND REPLACEMENT METHOD BASED ON PRIME EDITING

#2056
20240011054
2024-01-11

CONSTRUCTS AND USES THEREOF FOR EFFICIENT AND SPECIFIC GENOME EDITING

#2057
20240011053
2024-01-11

Method of early diagnosis and composition of gRNA for treating mental health diseases using genome editing and cell and gene therapy

#2058
20240011052
2024-01-11

Genome editing method

#2059
20240011042
2024-01-11

EXCISABLE PLANT TRANSGENIC LOCI WITH SIGNATURE PROTOSPACER ADJACENT MOTIFS OR SIGNATURE GUIDE RNA RECOGNITION SITES

#2060
20240011037
2024-01-11

MEDIATORS OF GENE SILENCING

#2061
20240011031
2024-01-11

COMPOSITIONS COMPRISING A NUCLEASE AND USES THEREOF

#2062
20240011030
2024-01-11

TREATMENTS FOR RETINAL DEGENERATIVE DISEASES

#2063
20240011023
2024-01-11

HYBRIDIZED GUIDE NUCLEIC ACIDS FOR USE WITH TEMPLATE-BASED GENE EDITORS

#2064
20240011007
2024-01-11

GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC GRANULOMATOUS DISEASE

#2065
20240011006
2024-01-11

METHODS AND MEANS OF INACTIVATING RNA BASED VACCINES

#2066
20240011005
2024-01-11

NOVEL CRISPR-CAS12F SYSTEMS AND USES THEREOF

#2067
20240011004
2024-01-11

COMPOSITIONS COMPRISING A VARIANT CRISPR NUCLEASE POLYPEPTIDE AND USES THEREOF

#2068
20240011003
2024-01-11

ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE TRANSTHYRETIN GENE

#2069
20240011002
2024-01-11

DAUGHTERLESS MALE MAMMALS FOR NON-HUMAN POPULATION SUPPRESSION

#2070
20240010991
2024-01-11

MATERIALS AND METHODS FOR BIOENGINEERED IPSC POPULATIONS

#2071
20240010988
2024-01-11

GENETICALLY MODIFIED PRIMARY CELLS FOR ALLOGENEIC CELL THERAPY

#2072
20240010977
2024-01-11

METHODS FOR ENHANCING THERAPEUTIC EFFICACY OF ISOLATED CELLS FOR CELL THERAPY

#2073
20240009294
2024-01-11

HPV therapeutic nucleic acid vaccine

#2074
20240008461
2024-01-11

CRUCIAN CARP (CARASSIUS AURATUS) STRAIN WITHOUT INTERMUSCULAR BONES AND BREEDING METHOD THEREOF

#2075
20240008460
2024-01-11

JAK3 GENE-MUTATED, SEVERE COMBINED IMMUNODEFICIENCY ANIMAL MODEL AND CONSTRUCTION METHOD THEREFOR

#2076
20240002956
2024-01-04

SENSITIVE QUANTITATIVE DETECTION OF SARS-CoV-2 USING DIGITAL WARM-START CRISPR ASSAY

#2077
20240002921
2024-01-04

RNA and DNA analysis using engineered surfaces

#2078
20240002886
2024-01-04

Methods and compositions for modulating a genome

#2079
20240002885
2024-01-04

PLASMID FOR TRANSFORMATION, METHOD FOR PRODUCING TRANSFORMANT USING THE SAME, AND TRANSFORMATION METHOD

#2080
20240002880
2024-01-04

Controllable Transcription

#2081
20240002878
2024-01-04

Universal platform to enhance CRISPR-based gene editing for in vivo therapies

#2082
20240002873
2024-01-04

METHODS AND COMPOSITIONS FOR CONTROLLING MERISTEM SIZE FOR CROP IMPROVEMENT

#2083
20240002868
2024-01-04

INSECT RESISTANT INIR6 TRANSGENIC MAIZE PLANTS LACKING A SELECTABLE MARKER AND JUNCTION

#2084
20240002841
2024-01-04

MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES

#2085
20240002839
2024-01-04

CRISPR SAM BIOSENSOR CELL LINES AND METHODS OF USE THEREOF

#2086
20240002835
2024-01-04

GENETIC TOOL FOR THE TRANSFORMATION OF CLOSTRIDIUM BACTERIA

#2087
20240002834
2024-01-04

ADENINE BASE EDITOR LACKING CYTOSINE EDITING ACTIVITY AND USE THEREOF

#2088
20240002823
2024-01-04

Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

#2089
20240002822
2024-01-04

Methods and compositions for modulating a genome

#2090
20240002821
2024-01-04

Optimized protein linkers and methods of use

#2091
20240002820
2024-01-04

Polynucleotides, Compositions, and Methods for Genome Editing Involving Deamination

#2092
20240002818
2024-01-04

MAMMALIAN MOBILE ELEMENT COMPOSITIONS, SYSTEMS AND THERAPEUTIC APPLICATIONS

#2093
20240002538
2024-01-04

METHOD FOR THE ASSEMBLY OF LARGE NUCLEIC ACIDS FROM SHORT FRAGMENTS

#2094
20240000972
2024-01-04

RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING CAG REPEAT DISEASES

#2095
20240000970
2024-01-04

DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF LRRK2

#2096
20240000938
2024-01-04

ADOPTIVE CELL THERAPY FOR TREATMENT OF CANCER ASSOCIATED WITH LOSS OF HETEROZYGOSITY

#2097
20240000845
2024-01-04

OPTIMIZED ENGINEERED NUCLEASES HAVING SPECIFICITY FOR THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

#2098
20240000051
2024-01-04

INFLUENZA A-RESISTANT ANIMALS HAVING EDITED ANP32 GENES

#2099
20230416846
2023-12-28

DIGITAL CRISPR-BASED METHOD FOR THE RAPID DETECTION AND ABSOLUTE QUANTIFICATION OF NUCLEIC ACIDS

#2100
20230416828
2023-12-28

RNA and DNA analysis using engineered surfaces